Vimarsana
Biggest News Aggregation in the World

Page 2 - Aug 24 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aug 24. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aug 24 Today - Breaking & Trending Today

ROA urges President to reinstate military separated for vaccine refusal - Vimarsana News

ROA urges President to reinstate military separated for vaccine refusal

ROA leads military and veterans groups, calling reinstatement and back pay the right thing to do for troops and readiness

simPRO Expands Global Footprint with New Office Openings - Vimarsana News

simPRO Expands Global Footprint with New Office Openings

SimPRO accelerates its international expansion plans with two new office openings in high-growth markets of Singapore and the Netherlands BROOMFIELD, Colo., Aug. 24, 2022 /PRNewswire/ --simPRO, theglobal leader in trade business management software, is pleased to announce the opening of two new office spaces in Singapore and the Netherlands. These offices will help accommodate an aggressive global expansion strategy and commitment to growing their customer base around the world. The two new offices employ six local team members in each location in sales, businessdevelopment and implementation ...

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study - Vimarsana News

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

GENEVA, Switzerland, Aug. 24, 2022 /PRNewswire/ --The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the US in May 2022, with enrollment of the first patient occurring in Germany one week after approval. "We are very excited to finally have drug-eluting technology in the US to treat this difficult patient population," commented the trial's Principal Investigator (PI) Dr. Ehrin Armstrong...

Related Topics:
United StatesNorth CarolinaUnited KingdomSwitzerland GeneralRichard KenyonEhrin ArmstrongMa Med AllianceCell Adherent TechnologyVascular Solutions In CaryInvestigational Device ExemptionPrincipal InvestigatorDrug Eluting BalloonChronic Limb Threatening IschemiaVascular SolutionsBreakthrough Device DesignationMedalliance ChairmanAug 24022 Prnewswire The First Us Patient Has Been Enrolled In Fda Selution4btk Below Knee Clinical Trial Evaluating Selution SlrEdalliance 39s Novel Sirolimus Eluting Balloon This Milestone Follows Investigational Device Exemption Ide Approval In The Us May 2022Ith Enrollment Of The First Patient Occurring In Germany One Week After Approval Quot We Are Very Excited To Finally Have Drug Eluting Technology Us Treat This Difficult PopulationUot Commented The Trial 39s Principal Investigator Pi Dr Ehrin Armstrong Quot We Are Encouraged By Positive Early Outcomes With This Novel Selution Slr Sirolimus Drug Eluting Balloon Deb In Europe And Asia Hope Fda Ide Will Demonstrate Significant Benefit For Patients Who Currently Have Limited Treatment Options Aim Of Selution4btk Clinical Is To Superior Efficacy Equivalent Safety Compared Plain Uncoated Angioplasty Poba Btk Arteries Chronic Limb Threatening Ischemia Clti Isa ProspectiveMulti CenterSingle BlindedAndomized Study Clinicaltrials Gov Identifier Nct05055297 377 Subjects Are Being Randomized 1 To Either Selution Slr Or Control Treatment This Is The First Of Its Kind Where 39 Real World Patients With Clti Can Be Included Enrolled At Approximately 40 Sites Across UsUrope And Asia This First Us Patient Was Enrolled At Vascular Solutions In Cary
Announcing HH Global's new Net Zero targets - Vimarsana News

Announcing HH Global's new Net Zero targets

LONDON, Aug. 24, 2022 /PRNewswire/ -- HH Global is committed to being the first-choice, global, tech-enabled creative production and procurement partner to brands seeking stronger, more sustainable growth. Therefore, it is important that we are continually assessing and improving our ESG targets and framework, aligned to UN Sustainable Development Goals. We are updating our current carbon reduction targets to harmonize with the new science-based net-zero standard set out at the United Nations Climate Change Conference (COP26). The new standard is aligned with the science of the Paris Climate C...

Related Topics:
Glasgow CityUnited KingdomFrance GeneralCity OfUn Sustainable Development GoalsUnited Nations Climate Change ConferenceParis Climate Change AgreementCoca Cola Europacific PartnersAug 24022 Prnewswire Hh Global Is Committed To Being The First ChoiceEch Enabled Creative Production And Procurement Partner To Brands Seeking StrongerOre Sustainable Growth ThereforeT Is Important That We Are Continually Assessing And Improving Our Esg Targets FrameworkLigned To Un Sustainable Development Goals We Are Updating Our Current Carbon Reduction Targets Harmonize With The New Science Based Net Zero Standard Set Out At United Nations Climate Change Conference Cop26 Is Aligned Of Paris AgreementHich Aims To Limit Global Warming 1 5c During Cop26 In Glasgow Last YearA New Standard For Net Zero Was Introduced Prior To This There No Agreed Many Companies Planned Achieve Through 39 Carbon Offsets Hich Are Credits Generated By Projects Reducing Carbon Emissions Elsewhere HoweverAny Existing Carbon Offsets Are Of Inadequate Quality And Hard To VerifyIth Some Even Increasing Global Emissions The New Net Zero Standard Allows Less Room For Companies To Cut Corners Hh Plans Lead By Example This Is Requested Both Clients And InvestorsUch As Coca Cola Europacific PartnersNilever And Blackstone Having An Approved Target Will Ensure That We Havea Credible Science Based Carbon Reduction Pathway Further Maintains Our Position As Leaders In Sustainable Impact Accountability The Following Key Milestones To Achieve Net Zero Are Proposed For Hh Global 50 By 2030 90 2040 Ongoing Investment Nature Solutions 10 Neutralization Compared Toa Fy22 Baseline Achieving Requirea Collective Concerted Effort From Business Suppliers Alike Committed Collaboration With Both Clients Encourage Them Switch Renewable Energy Source Environmentally Friendly Materials Also Work Logistics Companies They Use Low Transport Leverage Insights Help Make Informed Purchasing Decisions Everyone Hasa Part Play This New AmbitionOsitive Well Informed Conversations Anda Clear Roadmap Is Critical We Will Continue To Ensure That Our Sustainability Objectives Are Fully Embedded Into Company Culture And Processes Make Sure Play Part In Protecting Planet For The Future About Hh Global Isa Tech EnabledReative Production And Procurement Partner That Delivers Big Impact For Ideas Across The Globe With 4500 Experts In Every Market Anda Thirty Year Track Record Of SuccessE Help The Biggest Brands On Planet Achieve Stronger
Eventus appoints industry veteran Robbie McDonnell Sales Director, Australia & New Zealand - Vimarsana News

Eventus appoints industry veteran Robbie McDonnell Sales Director, Australia & New Zealand

NEW YORK and SYDNEY, Aug. 24, 2022 /PRNewswire/ -- Eventus, a leading global provider of multi-asset class trade surveillance and market risk solutions, announced today that Robbie McDonnell has joined the firm as Sales Director, Australia & New Zealand. McDonnell is a nearly 30-year veteran of financial markets technology, serving in a variety of senior roles, including in global sales and regional expansion in the Asia-Pacific (APAC) region. Based in Sydney, McDonnell is reporting to Scott Leader, the firm's Managing Director, APAC. Leader said: We're delighted Robbie has joined ...